Polymer Capital Management (Us) LLC Geron Corp Transaction History
Polymer Capital Management (Us) LLC
- $370 Billion
- Q4 2024
A detailed history of Polymer Capital Management (Us) LLC transactions in Geron Corp stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 23,998 shares of GERN stock, worth $61,434. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,998Holding current value
$61,434% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
305Shares Held
465MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$85.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$76.8 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$69.7 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$69.5 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $967M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...